Suchergebnisse - "Othman, Ahmed A"

PubPharm (310)

71

METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS

enthalten in: Europäisches Patentamt | 2022

von MACHADO DE LACERDA ANA PAULA | ENEJOSA JOSE JEFFREY V | PANGAN AILEEN L | +3

72

METHODS OF TREATING CROHN'S DISEASE AND ULCERATIVE COLITIS

enthalten in: Europäisches Patentamt | 2022

von MACHADO DE LACERDA ANA PAULA | ENEJOSA JOSE JEFFREY V | PANGAN AILEEN L | +3

73

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

enthalten in: Europäisches Patentamt | 2022

von MOHAMED MOHAMED-ESLAM F | OTHMAN AHMED A | KLÜNDER BEN | +2

74

Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers

enthalten in: Clinical and translational science | 2022

von Cherala, G. | Nelson, C. | Guo, Y. | +3

75

Valve-Preserving Root Reimplantation Combined with Arch Procedure : Optimizing Patient Selection

enthalten in: Innovations (Philadelphia, Pa.) | 2022

von Othman, A. | Elgharably, H. | Vargo, P. | +8

76

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

enthalten in: Europäisches Patentamt | 2022

von ALLIAN AYMAN | JAYANTH JAYANTHY | MOHAMED MOHAMED-ESLAM F | +10

77

Utility of Modeling and Simulation Approach to Support the Clinical Relevance of Dissolution Specifications : a Case Study from Upadacitinib Development

enthalten in: The AAPS journal | 2022

von Mohamed, M. | Winzenborg, I. | Othman, A. | +1

78

Utility of Modeling and Simulation Approach to Support the Clinical Relevance of Dissolution Specifications: a Case Study from Upadacitinib Development

enthalten in: The AAPS journal | 2022

von Mohamed, M. | Winzenborg, I. | Othman, A. | +1

79

Utility of Modeling and Simulation Approach to Support the Clinical Relevance of Dissolution Specifications: a Case Study from Upadacitinib Development

enthalten in: AAPS PharmSci | 2022

von Mohamed, M. | Winzenborg, I. | Othman, A. | +1

80

Evaluation of the potential drug interactions mediated through P-gp, OCT2, and MATE1/2K with filgotinib in healthy subjects

enthalten in: Clinical and translational science | 2022

von Hsueh, C. | Anderson, K. | Shen, G. | +3